Article
Genome-wide association analysis of treatment resistant schizophrenia for variant discovery and polygenic assessment
2024-07-18
Abstract excerpt
<title>Abstract</title> <p>Background Treatment resistant schizophrenia (TRS) is broadly defined as inadequate response to adequate treatment and is associated with a substantial increase in disease burden. Clozapine is the only approved treatment for TRS, showing superior clinical effect on overall symptomatology compared to other drugs, and is the prototype of atypical antipsychotics. Risperidone, another atyp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8a3eb6fc-98b3-5f79-beb9-d686c9d531b4
- DOI
- 10.21203/rs.3.rs-4614092/v1
